(Q43653880)

25 November 2017

title

The neuroprotective activity of the glycine receptor antagonist GV150526: an in vivo study by magnetic resonance imaging (English)

1 reference

25 November 2017

Reggiani A

1

1 reference

25 November 2017

Pietra C

2

1 reference

25 November 2017

Arban R

3

1 reference

25 November 2017

Marzola P

4

1 reference

25 November 2017

Guerrini U

5

1 reference

25 November 2017

Ziviani L

6

1 reference

25 November 2017

Boicelli A

7

1 reference

25 November 2017

Sbarbati A

8

1 reference

25 November 2017

Osculati F

9

1 reference

25 November 2017

language of work or name

English

0 references

publication date

1 May 2001

1 reference

European Journal of Pharmacology

25 November 2017

published in

1 reference

25 November 2017

volume

419

1 reference

25 November 2017

issue

2-3

1 reference

25 November 2017

page(s)

147-153

1 reference

describes a project that uses

25 November 2017

magnetic resonance imaging

1 reference

based on heuristic

inferred from title

cites work

Application of magnetic resonance imaging to the measurement of neurodegeneration in rat brain: MRI data correlate strongly with histology and enzymatic analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2900948-7

Mechanism of detection of acute cerebral ischemia in rats by diffusion-weighted magnetic resonance microscopy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2900948-7

The glycine antagonist GV150526 protects somatosensory evoked potentials and reduces the infarct area in the MCAo model of focal ischemia in the rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2900948-7

Evaluation of a competitive NMDA antagonist (D-CPPene) in feline focal cerebral ischemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2900948-7

Substituted indole-2-carboxylates as in vivo potent antagonists acting as the strychnine-insensitive glycine binding site.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2900948-7

New magnetic resonance techniques for evaluating cerebrovascular disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2900948-7

Systemic administration of MK-801 prevents N-methyl-D-aspartate-induced neuronal degeneration in rat brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2900948-7

A comparison of the early development of ischaemic damage following permanent middle cerebral artery occlusion in rats as assessed using magnetic resonance imaging and histology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2900948-7

Neuroprotection in acute ischaemic stroke: a tale of for whom the bell tolls?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2900948-7

Limiting ischemic injury by inhibition of excitatory amino acid release

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2900948-7

The competitive NMDA antagonist MDL-100,453 reduces infarct size after experimental stroke

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2900948-7

Pharmacokinetics of a glycine site antagonist (gavestinel) following multiple dosing in patients with acute stroke

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2900948-7

MR imaging of intravoxel incoherent motions: application to diffusion and perfusion in neurologic disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2900948-7

The changing landscape of ischaemic brain injury mechanisms.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2900948-7

Glycine antagonist (gavestinel) in neuroprotection (GAIN International) in patients with acute stroke: a randomised controlled trial. GAIN International Investigators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2900948-7

Effect of brain edema on infarct volume in a focal cerebral ischemia model in rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2900948-7

Pharmacologic reversal of acute changes in diffusion-weighted magnetic resonance imaging in focal cerebral ischemia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2900948-7

Diffusion-weighted magnetic resonance imaging: rapid and quantitative detection of focal brain ischemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2900948-7

Effects of a novel NMDA antagonist on experimental stroke rapidly and quantitatively assessed by diffusion-weighted MRI.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2900948-7

Diffusion and perfusion magnetic resonance imaging studies to evaluate a noncompetitive N-methyl-D-aspartate antagonist and reperfusion in experimental stroke in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2900948-7

Protective effect of the glutamate antagonist, MK-801 in focal cerebral ischemia in the cat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2900948-7

The glutamate antagonist MK-801 reduces focal ischemic brain damage in the rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2900948-7

Focal cerebral ischaemia in the cat: treatment with the glutamate antagonist MK-801 after induction of ischaemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2900948-7

The evolution of acute stroke recorded by multimodal magnetic resonance imaging.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2900948-7

Calcium antagonists reduce the extent of infarction in rat middle cerebral artery occlusion model as determined by quantitative magnetic resonance imaging.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2900948-7

New nitro-monotetrazolium salts and their use in histochemistry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2900948-7

Blockade of N -Methyl-D-Aspartate Receptors May Protect Against Ischemic Damage in the Brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2900948-7

Cerebroprotective effect of a non-N-methyl-D-aspartate antagonist, GYKI 52466, after focal ischemia in the rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2900948-7

Protective effect of N-methyl-D-aspartate antagonists after focal cerebral ischemia in rabbits

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2900948-7

Recommendations for standards regarding preclinical neuroprotective and restorative drug development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2900948-7

Glycine site antagonist attenuates infarct size in experimental focal ischemia. Postmortem and diffusion mapping studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2900948-7

Focal Cerebral Ischaemia in the Rat: 1. Description of Technique and Early Neuropathological Consequences following Middle Cerebral Artery Occlusion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2900948-7

Delayed treatment with an adenosine kinase inhibitor, GP683, attenuates infarct size in rats with temporary middle cerebral artery occlusion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2900948-7

Protective effect of GV150526A on the glutamate-induced changes in basal and electrically-stimulated cytosolic Ca++ in primary cultured cerebral cortical cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2900948-7

U50488 reduces the severity of tissue damage in a rabbit model of focal cerebral ischemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2900948-7

Delayed treatment with AMPA, but not NMDA, antagonists reduces neocortical infarction.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2900948-7

10.1016/S0014-2999(01)00948-7

7 January 2021

Identifiers

DOI

1 reference

25 November 2017

1 reference